Insider Selling Aadi Bioscience, Inc. Chairman Sells 13,889 Shares of Stock

AADI Stock  USD 2.34  0.06  2.63%   
Under 57% of all Aadi Bioscience's traders are looking to take a long position. The analysis of the overall investor sentiment regarding Aadi Bioscience suggests that some traders are interested. Aadi Bioscience's investing sentiment shows overall attitude of investors towards Aadi Bioscience.
  
Aadi Bioscience, Inc. Chairman Neil Desai sold 13,889 shares of Aadi Bioscience stock in a transaction dated Friday, September 1st. The shares were sold at an average price of 5.97, for a total value of 82,917.33. Following the sale, the chairman now owns 1,691,654 shares of the companys stock, valued

Read at thelincolnianonline.com
news
  

Aadi Bioscience Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Aadi Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Aadi Bioscience Fundamental Analysis

We analyze Aadi Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aadi Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aadi Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Working Capital

Working Capital Comparative Analysis

Aadi Bioscience is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Aadi Bioscience Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aadi Bioscience stock to make a market-neutral strategy. Peer analysis of Aadi Bioscience could also be used in its relative valuation, which is a method of valuing Aadi Bioscience by comparing valuation metrics with similar companies.

Peers

Aadi Bioscience Related Equities

ANTXAN2 Therapeutics   21.90   
0%
100.0%
GLUEMonte Rosa   13.72   
0%
62.0%
ARVNArvinas   2.85   
0%
13.0%
ADAGAdagene   1.30   
0%
5.0%
RZLTRezolute   1.00   
0%
4.0%
ACRVAcrivon Therapeutics,   0.80   
0%
3.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
3.0%
DSGNDesign Therapeutics   0.50   
0%
2.0%
AVTEAerovate Therapeutics   0.38   
1.0%
0%
ANABAnaptysBio   0.64   
2.0%
0%
CRNXCrinetics Pharmaceuticals   0.81   
3.0%
0%
RAREUltragenyx   1.04   
4.0%
0%
KURAKura Oncology   1.16   
5.0%
0%
RVMDRevolution Medicines   1.25   
5.0%
0%
ERASErasca   2.05   
9.0%
0%
MLYSMineralys Therapeutics,   2.59   
11.0%
0%

Complementary Tools for Aadi Stock analysis

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
CEOs Directory
Screen CEOs from public companies around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities